Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/23246
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRodríguez, Miguel-
dc.contributor.authorGutiérrez, Joyce-
dc.contributor.authorDomínguez, José-
dc.contributor.authorPeixoto, Philippe A.-
dc.contributor.authorFernández, Alexis-
dc.contributor.authorRodríguez, Noris-
dc.contributor.authorDeffieux, Denis-
dc.contributor.authorRojas, Luis-
dc.contributor.authorQuideau, Stéphane-
dc.contributor.authorPouységu, Laurent-
dc.contributor.authorCharris, Jaime-
dc.date.accessioned2024-11-21T18:28:27Z-
dc.date.available2024-11-21T18:28:27Z-
dc.date.issued2020-03-16-
dc.identifier.citationMicheel M. Vichi-Ramírez, Edgar López-López, Catalina Soriano-Correa, Carolina Barrientos-Salcedo, Using 5-Nitroimidazole Derivatives against Neglected Tropical Protozoan Diseases: Systematic Review, Future Pharmacology, 10.3390/futurepharmacol4010015, 4, 1, (222-255), (2024). Shweta Bisht, Lalan Kumar, Grace Kaul, Abdul Akhir, Deepanshi Saxena, Sidharth Chopra, R. Karthik, Neena Goyal, Sanjay Batra, Synthesis and Biological Evaluation of Substituted 3‐Isoxazolethioethers as Antileishmanial and Antibacterial Agents, ChemistrySelect, 10.1002/slct.202201664, 7, 25, (2022). Dinesh S. Reddy, Anamika Sinha, Amit Kumar, Vipin K. Saini, Drug re‐engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery, Archiv der Pharmazie, 10.1002/ardp.202200214, 355, 11, (2022). Wilmer Alcazar, Sami Alakurtti, Maritza Padrón-Nieves, Maija Liisa Tuononen, Noris Rodríguez, Jari Yli-Kauhaluoma, Alicia Ponte-Sucre, Leishmanicidal Activity of Betulin Derivatives in Leishmania amazonensis; Effect on Plasma and Mitochondrial Membrane Potential, and Macrophage Nitric Oxide and Superoxide Production, Microorganisms, 10.3390/microorganisms9020320, 9, 2, (320), (2021). Om P.S. Patel, Omobolanle Janet Jesumoroti, Lesetja J. Legoabe, Richard M. Beteck, Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective, European Journal of Medicinal Chemistry, 10.1016/j.ejmech.2020.112994, 210, (112994), (2021).en_US
dc.identifier.issn0365-6233-
dc.identifier.urihttp://hdl.handle.net/10872/23246-
dc.description.abstractA series of new nitroimidazole-containing derivatives was synthesized by coupling of 2-[2-(2-methyl-5-nitro-1H-imidazol-1- l)ethylthio]ethanol with diversely substituted benzoic acids. Upon treatment with m-CPBA, 12 of these sulfanyl compounds were further oxidized to their sulfonyl analogs. All the 26 synthetic compounds were examined for in vitro activity against Leishmania (V.) braziliensis and Leishmania (L.) mexicana, and some of them displayed an efficient antileishmanial activity. Among the compounds tested, the catecholic derivative 2-{[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]sulfanyl}ethyl 3,4-dihydroxybenzoate (9a, LC50 = 13 and 11 µM) and the pyrogallolic derivative 2-{[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]sulfanyl}ethyl 3,4,5-trihydroxybenzoate (9b, LC50 = 4 and 1 µM) were the most active ones against the two Leishmania strains.en_US
dc.language.isoen_USen_US
dc.publisherDPhG Arch Pharmen_US
dc.subjectNitroimidazole‐containing derivativesen_US
dc.subjectLeishmania (V.) braziliensisen_US
dc.subjectLeishmania (L.) mexicanaen_US
dc.subjectAntileishmanial activityen_US
dc.subjectCatecholic derivativeen_US
dc.subjectPyrogallolic derivativeen_US
dc.subjectVisceral leishmaniasis (VL)en_US
dc.subjectCutaneous leishmaniasis (CL)en_US
dc.subjectMucocutaneous leishmaniasis (MCL)en_US
dc.subjectPentavalent antimony compoundsen_US
dc.subjectMiltefosineen_US
dc.subjectNitroaromatic scaffoldsen_US
dc.subjectMetronidazole analogsen_US
dc.subjectSynthesisen_US
dc.subjectNuclear magnetic resonance (NMR)en_US
dc.subjectInfrared (IR)en_US
dc.subjectBiological evaluationen_US
dc.subjectLC50 valuesen_US
dc.titleSynthesis and leishmanicidal evaluation of sulfanyl‐and sulfonyl‐tethered functionalized benzoate derivatives featuring a nitroimidazole moietyen_US
dc.typeArticleen_US
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
Arch Pharm 2020.pdf1.17 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.